CA125-Associated Activated Partial Thromboplastin Time and Thrombin Time Decrease in Patients with Adenomyosis

References

• Bulun SE, Yildiz S, Adli M, Wei JJ. Adenomyosis pathogenesis: insights from next-generation sequencing. Human Reprod Update. 2021;27(6):1086–1097. doi:10.1093/humupd/dmab017
   PubMed Web of Science ®Google Scholar
• Donnez J, Donnez O, Dolmans MM. Introduction: uterine adenomyosis, another enigmatic disease of our time. Fertil Sterility. 2018;109(3):369–370. doi:10.1016/j.fertnstert.2018.01.035
   PubMed Web of Science ®Google Scholar
• Struble J, Reid S, Bedaiwy MA. Adenomyosis: a clinical review of a challenging gynecologic condition. J Minim Invasive Gynecol. 2016;23(2):164–185. doi:10.1016/j.jmig.2015.09.018
   PubMed Web of Science ®Google Scholar
• Gordts S, Grimbizis G, Campo R. Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis. Fertil Sterility. 2018;109(3):380–388.e381. doi:10.1016/j.fertnstert.2018.01.006
   PubMed Web of Science ®Google Scholar
• Yamanaka A, Kimura F, Yoshida T, et al. Dysfunctional coagulation and fibrinolysis systems due to adenomyosis is a possible cause of thrombosis and menorrhagia. Eur J Obstet Gynecol Reprod Biol. 2016;204:99–103. doi:10.1016/j.ejogrb.2016.07.499
   PubMed Web of Science ®Google Scholar
• Lin Q, Li T, Ding S, Yu Q, Zhang X. Anemia-associated platelets and plasma prothrombin time increase in patients with adenomyosis. J Clin Med. 2022;11(15):4382. doi:10.3390/jcm11154382
   PubMed Web of Science ®Google Scholar
• Guo SW. The role of platelets in the pathogenesis and pathophysiology of adenomyosis. J Clin Med. 2023;12(3). doi:10.3390/jcm12030842
   Web of Science ®Google Scholar
• Ding S, Lin Q, Zhu T, et al. Is there a correlation between inflammatory markers and coagulation parameters in women with advanced ovarian endometriosis? BMC Womens Health. 2019;19(1):169. doi:10.1186/s12905-019-0860-9
   PubMed Web of Science ®Google Scholar
• Zhang HY, Wang AQ, Zhu S, et al. 子宫腺肌症患者凝血功能的变化 [Changes of coagulation function in patients with adenomyosis]. Zhonghua Fu Chan Ke Za Zhi. 2022;57(3):179–189. Chinese. doi:10.3760/cma.j.cn112141-20211229-00759
   PubMedGoogle Scholar
• Yin X, Wu J, Song S, Zhang B, Chen Y. Cerebral infarcts associated with adenomyosis: a rare risk factor for stroke in middle-aged women: a case series. BMC Neurol. 2018;18(1):213. doi:10.1186/s12883-018-1213-2
   PubMedGoogle Scholar
• Uchino K, Shimizu T, Mizukami H, et al. Nonbacterial thrombotic endocarditis complicated by cerebral infarction in a patient with adenomyosis with high serum CA125 level; a case report. J Stroke Cerebrovasc Dis. 2018;27(3):e42–e45. doi:10.1016/j.jstrokecerebrovasdis.2017.09.064
   PubMed Web of Science ®Google Scholar
• Aiura R, Nakayama S, Yamaga H, Kato Y, Fujishima H. Systemic thromboembolism including multiple cerebral infarctions with middle cerebral artery occlusion caused by the progression of adenomyosis with benign gynecological tumor: a case report. BMC Neurol. 2021;21(1):14. doi:10.1186/s12883-021-02045-7
   PubMed Web of Science ®Google Scholar
• Akira S, Iwasaki N, Ichikawa M, et al. Successful long-term management of adenomyosis associated with deep thrombosis by low-dose gonadotropin-releasing hormone agonist therapy. Clin Exp Obstet Gynecol. 2009;36(2):123–125.
   PubMed Web of Science ®Google Scholar
• Son J, Lee DW, Seong EY, et al. Acute kidney injury due to menstruation-related disseminated intravascular coagulation in an adenomyosis patient: a case report. J Korean Med Sci. 2010;25(9):1372–1374. doi:10.3346/jkms.2010.25.9.1372
   PubMed Web of Science ®Google Scholar
• Zhou Q, Zhu C, Shen Z, et al. Incidence and potential predictors of thromboembolic events in epithelial ovarian carcinoma patients during perioperative period. Eur J Surg Oncol. 2020;46(5):855–861. doi:10.1016/j.ejso.2020.01.026
   PubMed Web of Science ®Google Scholar
• Kil K, Chung J, Pak H, et al. Usefulness of CA125 in the differential diagnosis of uterine adenomyosis and myoma. Eur J Obstet Gynecol Reprod Biol. 2015;185:131–135. doi:10.1016/j.ejogrb.2014.12.008
   PubMed Web of Science ®Google Scholar
• Tang Y, Ming-Tao Y, Xiang R, et al. Preoperative CA125 as a risk factor for symptom recurrence of adenomyosis after ultrasound-guided high-intensity focused ultrasound ablation surgery. Int j Hyperthermia. 2022;39(1):1164–1169. doi:10.1080/02656736.2022.2107716
   PubMed Web of Science ®Google Scholar
• Jiang C, Liu C, Guo J, et al. CA125 modified by PLT and NLR improves the predictive accuracy of adenomyosis-derived pelvic dense adhesion. Medicine. 2017;96(19):e6880.
   PubMed Web of Science ®Google Scholar
• Kannel WB. Oral contraceptive hypertension and thromboembolism. Int J Obstet Gynaecol. 1978;16(6):466–472. doi:10.1002/j.1879-3479.1979.tb00951.x
   Google Scholar
• Lim HS, MacFadyen RJ, Bakris G, Lip GY. The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: implications for hypertension management. Curr Pharm Des. 2006;12(13):1567–1579. doi:10.2174/138161206776843322
   PubMed Web of Science ®Google Scholar
• Jovin T, Boosupalli V, Zivkovic S, Wechsler L, Gebel JJN. High titers of CA-125 may be associated with recurrent ischemic strokes in patients with cancer. Neurology. 2005;64(11):1944–1945. doi:10.1212/01.WNL.0000163850.07976.63
   PubMed Web of Science ®Google Scholar
• Korte W, Clarke S, Lefkowitz JB. Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism. Am J Clin Pathol. 2000;113(1):123–127. doi:10.1309/G98J-ANA9-RMNC-XLYU
   PubMed Web of Science ®Google Scholar
• Mina A, Favaloro EJ, Mohammed S, Koutts J. A laboratory evaluation into the short activated partial thromboplastin time. Blood Coagul Fibrinolysis. 2010;21(2):152–157. doi:10.1097/MBC.0b013e3283365770
   PubMed Web of Science ®Google Scholar
• Mina A, Favaloro EJ, Koutts J. Relationship between short activated partial thromboplastin times, thrombin generation, procoagulant factors and procoagulant phospholipid activity. Blood Coagul Fibrinolysis. 2012;23(3):203–207. doi:10.1097/MBC.0b013e32834fa7d6
   PubMed Web of Science ®Google Scholar
• Tripodi A, Chantarangkul V, Martinelli I, Bucciarelli P, Mannucci PM. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood. 2004;104(12):3631–3634. doi:10.1182/blood-2004-03-1042
   PubMed Web of Science ®Google Scholar
• Tanaka K, Terada R, Butt A, Mazzeffi M, McNeil JJA. Factor VIII: a dynamic modulator of hemostasis and thrombosis in Trauma. Anesthesia Analg. 2023;136(5):894–904. doi:10.1213/ANE.0000000000006356
   PubMed Web of Science ®Google Scholar
• Zwaginga JJ, Koomans HA, Sixma JJ, Rabelink TJ. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions. J Clin Invest. 1994;93(1):204–211. doi:10.1172/JCI116947
   PubMed Web of Science ®Google Scholar
• Zhang Q, Duan J, Liu X, Guo SW. Platelets drive smooth muscle metaplasia and fibrogenesis in endometriosis through epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation. Mol Cell Endocrinol. 2016;428:1–16. doi:10.1016/j.mce.2016.03.015
   PubMed Web of Science ®Google Scholar
• Yang B, Gu N, Shi S, et al. Immunoreactivity of plasminogen activator inhibitor 1 and its correlation with dysmenorrhea and lesional fibrosis in adenomyosis. Reprod Sci. 2021;28(8):2378–2386. doi:10.1007/s43032-021-00513-6
   PubMed Web of Science ®Google Scholar
• Liu X, Guo SW. Aberrant immunoreactivity of deoxyribonucleic acid methyltransferases in adenomyosis. Gynecol Obstet Invest. 2012;74(2):100–108. doi:10.1159/000337718
   PubMed Web of Science ®Google Scholar
• Wada H, Shiraki K, Matsumoto T, et al. A clot waveform analysis of thrombin time using a small amount of thrombin is useful for evaluating the clotting activity of plasma independent of the presence of emicizumab. J Clin Med. 2022;11(20):6142. doi:10.3390/jcm11206142
   PubMed Web of Science ®Google Scholar
• Wada H, Ichikawa Y, Ezaki M, et al. The reevaluation of thrombin time using a clot waveform analysis. J Clin Med. 2021;10(21):4840. doi:10.3390/jcm10214840
   PubMed Web of Science ®Google Scholar
• Byrnes JR, Wolberg AS. Red blood cells in thrombosis. Blood. 2017;130(16):1795–1799. doi:10.1182/blood-2017-03-745349
   PubMed Web of Science ®Google Scholar
• Faes C, Ilich A, Sotiaux A, et al. Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease. Blood. 2019;133(23):2529–2541. doi:10.1182/blood.2019000424
   PubMed Web of Science ®Google Scholar
• Ling X, Wang T. Diagnostic and prognostic value of coagulation-related factors in endometriosis. Am J Transl Res. 2022;14(11):7924–7931.
   PubMed Web of Science ®Google Scholar
• Ding D, Liu X, Guo S. Further evidence for hypercoagulability in women with ovarian endometriomas. Reprod Sci. 2018;25(11):1540–1548. doi:10.1177/1933719118799195
   PubMed Web of Science ®Google Scholar
• Viganò P, Ottolina J, Sarais V, Rebonato G, Somigliana E, Candiani M. Coagulation status in women with endometriosis. Reprod Sci. 2018;25(4):559–565. doi:10.1177/1933719117718273
   PubMed Web of Science ®Google Scholar
• Shao B, Wahrenbrock MG, Yao L, et al. Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of trousseau syndrome. Blood. 2011;118(15):4015–4023. doi:10.1182/blood-2011-07-368514
   PubMed Web of Science ®Google Scholar
• Akaishi T, Kuroda H, Tateyama M, et al. Recurrent cerebral infarction synchronous with menorrhagia caused by endometrial stromal sarcoma. J Neurol Sci. 2015;358(1–2):509–511. doi:10.1016/j.jns.2015.09.367
   PubMed Web of Science ®Google Scholar
• Yan Y, Zhang X, Zhong D, Wang A, Wu S, Wu B. Adenomyosis-associated ischemic stroke: pathophysiology, detection and management. Brain Sci. 2022;12(10):1410. doi:10.3390/brainsci12101410
   PubMed Web of Science ®Google Scholar
• Li B, Shi K, Jing C, et al. Successful management of cerebral venous sinus thrombosis due to adenomyosis: case reports and literature review. Clin Neurol Neurosurg. 2023;229:107726. doi:10.1016/j.clineuro.2023.107726
   PubMed Web of Science ®Google Scholar